CBD's Anti-Addiction Effects on Methamphetamine Work Through Hippocampal Dopamine Receptors
CBD's ability to speed up extinction and prevent reinstatement of methamphetamine-seeking behavior in rats was partially blocked when D2 dopamine receptors in the hippocampus were inhibited.
Quick Facts
What This Study Found
A D2-like receptor antagonist (Sulpiride) at 1 and 4 micrograms significantly attenuated CBD's acceleration of methamphetamine conditioned place preference extinction (p<0.01, p<0.05). During reinstatement, the same doses reversed CBD's prevention of reward-seeking behavior (p<0.05, p<0.001), indicating CBD's anti-addiction effects are partially mediated through hippocampal D2 receptors.
Key Numbers
Sulpiride 1 and 4 micrograms attenuated CBD extinction effects (p<0.01, p<0.05); Sulpiride reversed CBD reinstatement prevention (p<0.05, p<0.001); CBD 10 micrograms for extinction, 50 micrograms for reinstatement; 10-day extinction period.
How They Did This
Rats received Sulpiride (D2 antagonist, 0.25-4 micrograms) into the hippocampal CA1 region before CBD (ICV) during a 10-day methamphetamine CPP extinction period or on reinstatement day. CBD doses were 10 micrograms (extinction) and 50 micrograms (reinstatement).
Why This Research Matters
Methamphetamine use disorder has no approved pharmacological treatments. This study identifies a specific brain mechanism (hippocampal D2 receptors) through which CBD exerts its anti-addiction effects, potentially informing more targeted therapeutic development.
The Bigger Picture
CBD has shown promise for various substance use disorders in preclinical models, but the mechanisms have been unclear. This study pins one mechanism to D2 receptors in the hippocampus, a brain region critical for drug-related memory processing.
What This Study Doesn't Tell Us
Animal model with direct brain injection of CBD, which differs from how humans consume CBD. CPP is a model of drug reward but does not capture all aspects of human addiction. Results from one brain region may not explain CBD's full anti-addiction profile.
Questions This Raises
- ?Would oral or systemic CBD produce the same hippocampal D2-mediated effects?
- ?Are other brain regions also involved in CBD's anti-meth effects?
- ?Could these findings inform CBD dosing strategies for human meth addiction trials?
Trust & Context
- Key Stat:
- CBD's anti-meth addiction effects were partially blocked by hippocampal D2 receptor inhibition
- Evidence Grade:
- Preliminary: Mechanistic animal study using direct brain injections; provides important pathway evidence but requires translation to human-relevant delivery and models.
- Study Age:
- Published in 2025.
- Original Title:
- Cannabidiol mechanism of action on modulating extinction and reinstatement of methamphetamine-seeking behavior: Targeting D2-like dopamine receptors in the hippocampus.
- Published In:
- Journal of psychiatric research, 189, 200-210 (2025)
- Authors:
- Omidiani, Seyed Erfan, Mohammadi, Mahsa, Seddighfar, Masoud, Azizbeigi, Ronak, Haghparast, Abbas
- Database ID:
- RTHC-07283
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Could CBD help people quit methamphetamine?
This animal study provides mechanistic evidence that CBD affects meth-related brain pathways, but direct brain injection in rats is very different from human CBD use. Clinical trials in humans would be needed before any conclusions about treating meth addiction with CBD.
Why do D2 receptors in the hippocampus matter?
D2 dopamine receptors in the hippocampal CA1 region play a key role in processing drug-related memories and emotional signals. By working through these receptors, CBD may help weaken the memory associations that drive drug-seeking behavior.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-07283APA
Omidiani, Seyed Erfan; Mohammadi, Mahsa; Seddighfar, Masoud; Azizbeigi, Ronak; Haghparast, Abbas. (2025). Cannabidiol mechanism of action on modulating extinction and reinstatement of methamphetamine-seeking behavior: Targeting D2-like dopamine receptors in the hippocampus.. Journal of psychiatric research, 189, 200-210. https://doi.org/10.1016/j.jpsychires.2025.06.011
MLA
Omidiani, Seyed Erfan, et al. "Cannabidiol mechanism of action on modulating extinction and reinstatement of methamphetamine-seeking behavior: Targeting D2-like dopamine receptors in the hippocampus.." Journal of psychiatric research, 2025. https://doi.org/10.1016/j.jpsychires.2025.06.011
RethinkTHC
RethinkTHC Research Database. "Cannabidiol mechanism of action on modulating extinction and..." RTHC-07283. Retrieved from https://rethinkthc.com/research/omidiani-2025-cannabidiol-mechanism-of-action
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.